Emily Shelley
Dermatology · Indianapolis, INNPI 1467834127
Payments from drug & device makers
Across 512 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sun Pharmaceutical Industries Inc.$1K
- Pfizer$891
- Novartis$797
- Sanofi$597
- Lilly USA, LLC$460
- plus $3K from 28 others
What the payments were for
- Food & beverage$8,43196%
- Education$3124%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,522 |
| Sun Pharmaceutical Industries Inc. | 71 | $1,143 |
| Pfizer | 57 | $891 |
| Novartis | 78 | $797 |
| Sanofi | 28 | $597 |
| Lilly USA, LLC | 23 | $460 |
| Galderma Laboratories, L.p. | 20 | $449 |
| Johnson & Johnson | 17 | $400 |
| E.r. Squibb & Sons, L.L.C. | 21 | $289 |
| LEO Pharma Inc. | 13 | $264 |
| Amgen | 12 | $242 |
| Dermavant Sciences, Inc. | 15 | $232 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $194 |
| Regeneron Healthcare Solutions, Inc. | 9 | $173 |
| Incyte Corporation | 8 | $164 |
| Mayne Pharma Commercial LLC | 8 | $147 |
| UCB, Inc. | 8 | $135 |
| Boehringer Ingelheim | 1 | $106 |
| Almirall LLC | 5 | $70 |
| Dermira, Inc. | 3 | $66 |
| Bristol Myers Squibb | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| VYNE Pharmaceuticals Inc. | 3 | $52 |
| Organon | 2 | $34 |
| Organogenesis Inc. | 1 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Biofrontera Inc. | 1 | $23 |
| EPI Health, LLC | 1 | $22 |
| Merz North America, Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Prugen, Inc. Pharmaceuticals | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,743 in reported general payments places this provider in the 65th percentile of 202 dermatology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 23 | $85,216 |
| Betamethasone Dipropionate | 54 | $1,702 |
| Doxycycline Hyclate | 46 | $1,320 |
| Imiquimod | 29 | $1,208 |
| Clobetasol Propionate | 26 | $1,170 |
| Ketoconazole | 67 | $964 |
| Metronidazole | 19 | $936 |
| Fluorouracil | 11 | $911 |
| Clindamycin Phosphate | 29 | $808 |
| Triamcinolone Acetonide | 114 | $803 |
| Hydroxyzine Hcl | 12 | $306 |
| Doxepin Hcl | 20 | $273 |
| MethotrexateMethotrexate Sodium | 35 | $267 |
| Prednisone | 46 | $233 |
| Fluconazole | 23 | $213 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Indianapolis
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
- Christopher ObeimeIndianapolis$907K
- Priya YoungIndianapolis$492K
- Nikolajs PerdueIndianapolis$302K
- Matthew TurnerIndianapolis$203K
- Stephen WolvertonIndianapolis$29K
- Annette DinneenIndianapolis$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.